Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They highlight the importance of regulatory reforms and a strong ecosystem for research and development. Industry executives mention that the next decade will be critical for this transformation and urge companies to capitalize on scientific talent. Government initiatives are acknowledged as supportive in this endeavor for global competitiveness.
Read more at The Economic Times
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.